1. Technical investigations into the cause of the increased incidence of antibody‐mediated pure red cell aplasia associated with EPREX®;Sharma B.;Eur. J. Hosp. Pharm.,2004
2. Leachables found in parenteral drug products;Castner J.;Am. Pharm. Rev.,2004
3. Challenges associated with extractable and/or leachable substances in therapeutic biologic protein products;Markovic I.;Am. Pharm. Rev.,2006
4. Root cause analysis of tungsten‐induced protein aggregation in pre‐filled syringes;Liu W.;PDA J. Pharm. Sci. Technol.,2010
5. Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity